Manikanta Murahari, PhD

About

I am a Medicinal Chemist, completed M. Pharm in Pharmaceutical Chemistry from Manipal University. Worked as Junior & Senior Research Fellow at SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai on a project funded by Department of Science & Technology (DST-SERB) titled-"Design and Synthesis of Novel acridone based derivatives and their anti-cancer & mechanistic studies". Awarded Ph.D From Jawaharlal Nehru Technological University Hyderabad (JNTUH).

Areas of interest- Medicinal Chemistry, Computer Aided Drug Design (CADD) and Cancer Biology

Employment

• Koneru Lakshmaiah Education Foundation Associate Professor
  2022 - Present
• M.S Ramaiah University of Applied Sciences Assistant Professor
  2015 - 2022
• SVKM's Dr. Bhanuben Nanavati College of Pharmacy Junior Research Fellow
  2012 - 2015

Education

• Manipal College of Pharmaceutical Sciences M.Pharm
  2009 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (61)

• In Silico Evaluation of Steroidal Alkaloids as Potential Dipeptidyl Peptidase‐4 (DPP‐4) Inhibitors for Type 2 Diabetes Mellitus
  ChemistrySelect 2026 DOI: 10.1002/slct.73899
  +Save
• Virtual screening and molecular fingerprinting for in silico designing of potential CCR5 inhibitors targeting HIV therapy
  Journal of Biomolecular Structure and Dynamics 2026 DOI: 10.1080/07391102.2024.2446668
  +Save
• In silico Optimization of Dihydroorotate dehydrogenase Inhibitors for Malaria viaDocking, Molecular Dynamics, and ADMET Evaluation
  Discover Molecules 2026 DOI: 10.1007/s44345-026-00045-z
  +Save
• Study of Class I HDAC-1, -2, and -3 Inhibitors Designed by Bioisosteric Replacement of Zinc Binding Groups and Caps of Traditional Pan Inhibitors: An In Silico Approach
  Current HIV Research 2026 DOI: 10.2174/011570162X379088251002114150
  +Save
• In Silico Approach for the Identification of Potential Marine Compounds Targeting GRK2 for Heart Failure Treatment
  ChemistrySelect 2026 DOI: 10.1002/slct.74258
  +Save
• Covalent Inhibitors - An Overview of Design Process, Challenges and Future Directions
  Current Organic Chemistry 2025 DOI: 10.2174/0113852728361926250123092017
  +Save
• Metronidazole—An Old Drug for Structure Optimization and Repurposing
  Chemistry & Biodiversity 2025 DOI: 10.1002/cbdv.202403389
  +Save
• Diaryl Diimidazopyrimidine Derivatives as Potent Inhibitors of Influenza A Virus: Synthesis, Evaluation and Docking Studies
  Drug Development Research 2025 DOI: 10.1002/ddr.70088
  +Save
• Biosimilar in Cervical Cancer
  2024 DOI: 10.1007/978-981-97-3001-8_5
  +Save
• LAG-3 Inhibitors for the Treatment of Lung Cancer
  2024 DOI: 10.1007/978-981-99-7141-1_8
  +Save